Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | ST6GAL1 | P15907 | 14/20 | 0.49 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aceneuramic Acid SCHEMBL7897261 | 0.92 | LMNA (0.54) | TSHRGLAST6GAL1P2RY2 | |
| Aceneuramic Acid SCHEMBL2302895 | 0.90 | LMNA (0.58) | TSHRGLAST6GAL1 | |
| SCHEMBL17422570 | 0.83 | ST6GAL1 (0.56) | TSHRGLAST6GAL1P2RY2 | |
| SCHEMBL3508694 | 0.81 | P2RY2 (0.56) | P2RY2 | |
| SCHEMBL4271244 | 0.81 | P2RY2 (0.56) | P2RY2 | |
| Cytarabine 5'-Phosphate SCHEMBL28003650 | 0.80 | P2RY2 (0.55) | TSHRGLAST6GAL1P2RY2 | |
| Cytarabine 5'-Phosphate SCHEMBL27855304 | 0.80 | P2RY2 (0.55) | TSHRGLAST6GAL1P2RY2 | |
| SCHEMBL10774561 | 0.80 | P2RY2 (0.48) | TSHRGLAST6GAL1P2RY2 | |
| Cytarabine 5'-Phosphate SCHEMBL28833023 | 0.79 | P2RY2 (0.60) | TSHRGLAST6GAL1P2RY2 | |
| Cytarabine 5'-Phosphate SCHEMBL28011040 | 0.79 | P2RY2 (0.55) | TSHRGLAST6GAL1P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240418701-A1 | SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE | NANJING UNIVERSITY (CN) | 2024-12-19 | — | — | US | claimed |
| EP-4413379-A1 | SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE | Nanjing University (CN) | 2024-08-14 | — | — | EP | claimed |
| CN-118103711-A | Single molecule identification with reactive heterogeneous nanopores | 南京大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117683833-A | Method for preparing nucleotide sugar from nucleoside monophosphate | 山东大学 | 2024-03-12 | — | — | CN | claimed |
| WO-2023056960-A1 | SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE | NANJING UNIVERSITY (CN) | 2023-04-13 | — | — | WO | claimed |
| WO-2021019104-A2 | A PRODUCTION HOST FOR PRODUCING HUMAN MILK OLIGOSACCHARIDES | BASF SE (DE) | 2021-02-04 | — | — | WO | claimed |
| US-9816107-B2 | Transgenic insect cells comprising a bacterial GlcNAc-6-P 2′-epimerase | THE UNIVERSITY OF WYOMING (US) | 2017-11-14 | — | — | US | claimed |
| US-9783838-B2 | PmST3 enzyme for chemoenzymatic synthesis of alpha-2-3-sialosides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-10-10 | — | — | US | claimed |
| US-20170204381-A1 | PMST1 MUTANTS FOR CHEMOENZYMATIC SYNTHESIS OF SIALYL LEWIS X COMPOUNDS | UNIV CALIFORNIA (US) | 2017-07-20 | — | — | US | claimed |
| US-20160015617-A1 | Compositions and Methods for Reducing Skin Pigmentation | YALE UNIVERSITY | 2016-01-21 | — | — | US | claimed |
| US-20030130175-A1 | Saccharide compositions, methods and apparatus for their synthesis | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2003-07-10 | — | — | US | claimed |
| EP-0481038-B1 | SACCHARIDE COMPOSITIONS, METHODS AND APPARATUS FOR THEIR SYNTHESIS | UNIV PENNSYLVANIA (US) | 2002-10-02 | — | — | EP | claimed |
| US-20020061550-A1 | Saccharide compositions, methods and apparatus for their synthesis | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2002-05-23 | — | — | US | claimed |
| US-20020045222-A1 | COMPOSITIONS AND METHODS FOR SACCHARIDE SYNTHESIS | ROTH STEPHEN (US) | 2002-04-18 | — | — | US | claimed |
| US-6331418-B1 | GLYCOSYLTRANSFERASE CAPABLE OF TRANSFERRING A PRESELECTED SACCHARIDE UNIT TO AN ACCEPTOR MOIETY IS ISOLATED BY CONTACTING ACCEPTOR MOIETY WITH GLYCOSYLTRANSFERASE; CATALYZING REACTION BETWEEN DONOR AND ACCEPTOR, REPEATING | NEOSE TECHNOLOGIES, INC. | 2001-12-18 | — | — | US | claimed |
| US-6187754-B1 | Sialyl-Lewisa and sialyl-Lewisx epitode analogues | GLYCOTECH CORP. | 2001-02-13 | — | — | US | claimed |
| US-5874261-A | Method for the purification of glycosyltransferases | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1999-02-23 | — | — | US | claimed |
| EP-0886639-A1 | SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES | GlycoTech Corp. (US) | 1998-12-30 | — | — | EP | claimed |
| WO-1997047641-A1 | NUCLEOTIDE SUGAR TRANSPORTERS AND USES THEREOF | UNIVERSITY OF MASSACHUSETTS (US) | 1997-12-18 | — | — | WO | claimed |
| WO-1997028174-A1 | SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES | NOVARTIS AG (CH) | 1997-08-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130175-A1 | Saccharide compositions, methods and apparatus for their synthesis | UGCG, OSTC, STT3A | TSHR 2977/4885GLA 275/4885ST6GAL1 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.